Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007247
Abstract: Key Points Bendamustine with rituximab was the preferred frontline regimen, while BTK inhibitors were preferred in second or later lines of therapy. The presence of chromosome 17p deletion or TP53 mutation did not shorten the… read more here.
Keywords: world treatment; patterns outcomes; outcomes mantle; treatment patterns ... See more keywords